Home
VACHU
VACHU News

Latest VOYAGER ACQUISITION CORP UNIT 1 COM & 1/2 WT EXP (VACHU) News on May 10, 2025

MT Newswires

5 days ago

OmniAb, Veraxa Biotech Partner on Solid Tumor Drug Discovery Program

GlobeNewswire

5 days ago

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

Veraxa to go public in $1.6bn SPAC deal with Voyager

Pharmaceutical Technology

17 days ago

Veraxa to go public in $1.6bn SPAC deal with Voyager

MT Newswires

17 days ago

Voyager Acquisition, VERAXA Biotech to Merge, Creating $1.64 Billion Public Cancer Therapy Company

GlobeNewswire

17 days ago

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

GlobeNewswire

7 months ago

Voyager Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about September 30, 2024

GlobeNewswire

9 months ago

Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering

GlobeNewswire

9 months ago

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Share on Social Networks: